Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, JMP …

16 hours ago  · Finally, HC Wainwright raised their price target on Exelixis from $29.00 to $40.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have …


$29.00
OFF

Exelixis (NASDAQ:EXEL) Stock Price Expected To Rise, JMP …

2 weeks from now

16 hours ago  · Finally, HC Wainwright raised their price target on Exelixis from $29.00 to $40.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have …

marketbeat.com

$1.52
OFF

Exelixis (NASDAQ:EXEL) Stock Price Expected To Rise, HC …

2 weeks from now

5 days ago  · Exelixis Price Performance. Shares of EXEL traded up $1.52 during mid-day trading on Friday, hitting $36.02. 3,120,368 shares of the company's stock were exchanged, …

marketbeat.com

$37.13
OFF

15 Analysts Have This To Say About Exelixis - Exelixis (NASDAQ:EXEL)

2 weeks from now

1 day ago  · In the assessment of 12-month price targets, analysts unveil insights for Exelixis, presenting an average target of $37.13, a high estimate of $42.00, and a low estimate of $29.00.

benzinga.com

$40.00
OFF

Exelixis (NASDAQ:EXEL) Stock, Analyst Ratings, Price Targets

2 weeks from now

6 days ago  · The latest price target for Exelixis (NASDAQ:EXEL) was reported by HC Wainwright & Co. on January 10, 2025. The analyst firm set a price target for $40.00 expecting EXEL to …

benzinga.com

$30.25
OFF

Analyst Ratings For Exelixis - Nasdaq

2 weeks from now

Oct 21, 2024  · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $30.25, a high estimate of $34.00, and a low estimate of $27.00.

nasdaq.com

18%
OFF

Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts …

2 weeks from now

Nov 1, 2024  · We would highlight that Exelixis' revenue growth is expected to slow, with the forecast 3.8% annualised growth rate until the end of 2025 being well below the historical 17% …

yahoo.com

$35.65
OFF

Exelixis (NASDAQ:EXEL) Stock Price Expected To Rise, Piper Sandler ...

2 weeks from now

1 day ago  · Shares of Exelixis stock opened at $35.65 on Monday. The stock has a 50-day simple moving average of $34.90 and a 200-day simple moving average of $28.99. Exelixis has a 52 …

etfdailynews.com

39%
OFF

Earnings Estimates Rising For Exelixis (EXEL): Will It Gain?

2 weeks from now

Nov 5, 2024  · For the current quarter, the company is expected to earn $0.46 per share, which is a change of +39.39% from the year-ago reported number. Over the last 30 days, seven …

yahoo.com

320%
OFF

Exelixis (EXEL) Earnings Expected To Grow: Should You Buy?

2 weeks from now

Oct 22, 2024  · This drug developer is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents a year-over-year change of +320%. Revenues are …

yahoo.com

$41.00
OFF

Oppenheimer Bullish On Exelixis Stock As Cabo Sales And R&D …

2 weeks from now

8 hours ago  · Wednesday - Oppenheimer has raised the price target for Exelixis (NASDAQ:EXEL) shares to $41.00 from the previous target of $38.00, while maintaining an Outperform rating on …

investing.com

90%
OFF

Why Exelixis (EXEL) Is Poised To Beat Earnings Estimates Again

2 weeks from now

1 day ago  · For the last reported quarter, Exelixis came out with earnings of $0.47 per share versus the Zacks Consensus Estimate of $0.42 per share, representing a surprise of 11.90%.

nasdaq.com

$2.16
OFF

Exelixis Sets 2025 Guidance In Line With Estimates

2 weeks from now

2 days ago  · Exelixis (NASDAQ:EXEL) expects $2.165B (consensus estimate: $2.17B) in total revenues for fiscal year 2024, with around ~$1.805B in net product revenues. The oncology …

seekingalpha.com

03%
OFF

Why Exelixis (EXEL) Is Poised To Beat Earnings Estimates Again

2 weeks from now

2 days ago  · Exelixis (EXEL) has an ... the company was expected to post earnings of $0.37 per share and it actually produced earnings of $0.84 per share, delivering a surprise of 127.03%. …

zacks.com

55%
OFF

Exelixis (EXEL) Stock Price, News & Analysis - MarketBeat

2 weeks from now

2 days ago  · Get The Latest EXEL Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. ... Earnings for Exelixis are expected to grow by 3.55% in …

marketbeat.com

$36.98
OFF

Exelixis Stock Hits 52-week High At $36.98 Amid Robust Growth

2 weeks from now

1 day ago  · Exelixis Inc . (NASDAQ: EXEL) stock soared to a 52-week high of $36.98, reflecting a remarkable year of growth for the biotechnology firm.Investors have shown increasing …

investing.com

$205
OFF

Exelixis Provides Preliminary 2024 Results And Outlook For 2025

2 weeks from now

2 days ago  · This is the third stock repurchase program undertaken by Exelixis since March 2023. Under this program, Exelixis repurchased $205.6 million of its common stock at an average …

yahoo.com

$36.98
OFF

Exelixis Stock Hits 52-week High At $36.98 Amid Robust Growth

2 weeks from now

1 day ago  · Exelixis Inc . (NASDAQ: EXEL) stock soared to a 52-week high of $36.98, reflecting a remarkable year of growth for the biotechnology firm. Investors have shown increasing …

investing.com

$36.98
OFF

Exelixis Stock Hits 52-week High At $36.98 Amid Robust Growth

2 weeks from now

1 day ago  · Exelixis Inc . (NASDAQ: EXEL) stock soared to a 52-week high of $36.98, reflecting a remarkable year of growth for the biotechnology firm. Investors have shown increasing …

investing.com

FAQs about Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, JMP … Coupon?

Should you buy Exelixis stock?

The average analyst rating for Exelixis stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP. Sources: Price targets and analyst ratings provided by Benzinga. ...

How much stock did Exelixis repurchase in 2024?

This is the third stock repurchase program undertaken by Exelixis since March 2023. Under this program, Exelixis repurchased $205.6 million of its common stock at an average price of $33.62 by the end of fiscal 2024. EXEL reports preliminary 2024 revenues. ...

Should investors buy Exelixis (Exel)?

Exelixis (EXEL) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. ...

Will Exelixis (Exel) deliver a year-over-year increase in earnings?

In This Article: EXEL Exelixis (EXEL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. ...

What is the approval rating of Exelixis' CEO?

75 employees have rated Exelixis Chief Executive Officer Michael M. Morrissey on Glassdoor.com. Michael M. Morrissey has an approval rating of 79% among the company's employees. ...

When did Exelixis repurchase its stock?

In August 2024, its board of directors authorized the repurchase of up to $500 million of the company’s common stock through the end of 2025. This is the third stock repurchase program undertaken by Exelixis since March 2023. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension